Accendra Health (ACH) vs TriSalus Life Sciences (TLSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TriSalus Life Sciences (TLSI) has outperformed Accendra Health (ACH) over the past year, losing 14.8% versus a loss of 90.6%. Over five years, TLSI leads with a -58.3% price change compared with -98.7% for ACH. TriSalus Life Sciences is the larger company by market cap ($249.9 million vs $33.1 million), about 7.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACH | TLSI |
|---|---|---|
| Share price | $0.4302 | $4.06 |
| Market cap | $33.08M | $249.86M |
| 1-day change | -2.93% | -1.75% |
| YTD return | -84.17% | -40.83% |
| 1-year return | -90.61% | -14.85% |
| 5-year return | -98.65% | -58.28% |
| Forward P/E | 4.72 | — |
| EPS (TTM) | $-1.44 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.60 | $7.95 |
| 52-week low | $0.42 | $2.20 |
| Distance from 52-week high | -92.32% | -48.96% |
| Analyst consensus | hold | none |
| Avg. price target upside | +251.00% | +156.30% |
| Average volume | 1.41M | 275.38K |
| Shares outstanding | 76.90M | 61.57M |
| Employees | 6,500 | 102 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TriSalus Life Sciences is about 7.6 times larger than Accendra Health by market value ($249.86M vs $33.08M).
- TLSI has outperformed ACH by 75.8 percentage points over the past year.
About Accendra Health
ACH stock →Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services.
Health Care · Medical Specialities · 6,500 employees
About TriSalus Life Sciences
TLSI stock →TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.
Health Care · Medical Specialities · 102 employees
ACH vs TLSI FAQ
Which is bigger, Accendra Health or TriSalus Life Sciences?
TriSalus Life Sciences (TLSI) is larger, with a market capitalization of $249.86M compared with $33.08M for Accendra Health (ACH).
Which stock has performed better over the past year, ACH or TLSI?
TLSI returned -14.85% over the past 12 months, compared with -90.61% for ACH (price return, excluding dividends). Past performance does not predict future results.
Are Accendra Health and TriSalus Life Sciences in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.